Ali S. Mohamed - Concepedia

Author

Ali S. Mohamed

Georgetown University Medical Center ORCID

Also Known As

A. Syed Mohamed, A.S. Mohamed, Ali Mohamed, Ali S. Mohamed, Ali Sobhy Mohamed, ali mohamed

109

Publications

400

Citations

H-Index

Concepts

All Affiliations

Georgetown University Medical Center Georgetown University National Institutes of Health

About

Ali S. Mohamed is an author at Georgetown University Medical Center specializing in cell signaling, medicine, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	274
2	Cell Biology	3	3	274
3	Cellular Physiology	2	2	212
4	Molecular Biology	1	1	113
5	Neuroscience	1	1	62

Ali S. Mohamed

Publications

385

Citations

H-Index

Page 1

	Year	Citations
Src-Class Kinases Act within the Agrin/MuSK Pathway to Regulate Acetylcholine Receptor Phosphorylation, Cytoskeletal Anchoring, and Clustering Ali S. Mohamed, Kimberly A. Rivas-Plata, Jonathan R. Kraas, Journal of Neuroscience Cytoskeletal AnchoringMolecular BiologyCytoskeletonAgrin/musk PathwayCellular Physiology	2001	113
Cardiac Myosin-Binding Protein C (MyBP-C): Identification of Protein Kinase A and Protein Kinase C Phosphorylation Sites Ali S. Mohamed, John David Dignam, Keith K. Schlender Archives of Biochemistry and Biophysics Cardiac MuscleCardiomyopathyProtein Kinase AMolecular PhysiologySignal Transduction	1998	99
MAP Kinase Signaling Cascade Dysfunction Specific to Alzheimer's Disease in Fibroblasts Wei-Qin Zhao, Lakshmi Ravindranath, Ali S. Mohamed, Neurobiology of Disease FibrosisAlzheimer's DiseaseSignal TransductionSignaling PathwayDementia	2002	62
Phosphorylation and Cytoskeletal Anchoring of the Acetylcholine Receptor by Src Class Protein-tyrosine Kinases Ali S. Mohamed, Sheridan L. Swope Journal of Biological Chemistry	1999	52
New Amide-Bearing Benzolactam-Based Protein Kinase C Modulators Induce Enhanced Secretion of the Amyloid Precursor Protein Metabolite sAPPα Alan P. Kozikowski, Ireneusz Nowak, Pavel A. Petukhov, Journal of Medicinal Chemistry	2002	46
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer Apostolia M. Tsimberidou, Kerstin Guenther, Börje S. Andersson, Cancer Immunology Research	2023	13

Page 1